Trial site
Centro Hospitalar De Entre O Douro E Vouga E.P.E.
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis4 trials
- Epilepsy3 trials
- Multiple sclerosis2 trials
- Alzheimer disease1 trial
- Crohn's disease1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Phase
- Phase 312 trials
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting2 trials
- Lead sponsor
- Xenon Pharmaceuticals Inc.3 trials
- AbbVie2 trials
- Abivax S.A.2 trials
- Janssen Research & Development, LLC2 trials
- Janssen Pharmaceutica N.V., Belgium1 trial
- and 3 more
Running trials
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy2 recruiting
Closed trials
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Active, not recruiting
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Active, not recruiting
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026